Nuvalent (NUVL) Shareholder's Equity (2020 - 2026)
Nuvalent (NUVL) Shareholder's Equity (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
502.95 Mn |
| 10 |
Nuvalent |
9.70 Bn |
9.70 Bn |
- |
1.17 Bn |
| Date | Value |
|---|
| Mar 31, 2026 |
1.17 Bn |
| Dec 31, 2025 |
1.25 Bn |
| Sep 30, 2025 |
845.40 Mn |
| Jun 30, 2025 |
939.74 Mn |
| Mar 31, 2025 |
1.01 Bn |
| Dec 31, 2024 |
1.07 Bn |
| Sep 30, 2024 |
1.12 Bn |
| Jun 30, 2024 |
637.04 Mn |
| Mar 31, 2024 |
675.04 Mn |
| Dec 31, 2023 |
700.56 Mn |
| Sep 30, 2023 |
395.98 Mn |
| Jun 30, 2023 |
421.15 Mn |
| Mar 31, 2023 |
443.97 Mn |
| Dec 31, 2022 |
462.98 Mn |
| Sep 30, 2022 |
236.58 Mn |
| Jun 30, 2022 |
252.99 Mn |
| Mar 31, 2022 |
268.92 Mn |
| Dec 31, 2021 |
285.04 Mn |
| Sep 30, 2021 |
301.13 Mn |
| Jun 30, 2021 |
-47.74 Mn |
